DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award
This grant funds pilot clinical trials for research on Amyotrophic Lateral Sclerosis (ALS).
About this program
The DoW Amyotrophic Lateral Sclerosis Research Program offers funding for pilot clinical trials aimed at advancing research on ALS. This program is designed to support innovative approaches that can lead to significant breakthroughs in understanding and treating this debilitating disease. Researchers and institutions focused on ALS are encouraged to apply for this funding to explore new therapeutic strategies and interventions. Eligible applicants include academic institutions, nonprofit organizations, and other entities engaged in ALS research. The program seeks to foster collaboration among researchers and promote the development of novel clinical trial methodologies. By providing financial support, the program aims to accelerate the pace of discovery and improve outcomes for individuals affected by ALS.
Eligibility
Academic institutions, nonprofit organizations, and other entities engaged in ALS research.